GSK loses bid to keep experts out of upcoming Zantac trial Ruchika Sharma25 March 2023 12:30 PM ISTGSK said in a statement it disagreed with the ruling and would defend the case at trial.
Heartburn drug: Sanofi expects decision on Zantac dispute with Boehringer in Q1 at earliest Ruchika Sharma5 Jan 2023 1:15 PM ISTOriginally marketed by a forerunner of GSK, the medicine has been sold at different times by companies including Pfizer, Boehringer, and Sanofi as...
US Federal Court assures safety from Ranitidine, dismisses 2,500 lawsuits alleging cancer linkage with drug Ruchika Sharma19 Dec 2022 3:48 PM ISTThe court ruling comes as a big win for pharmaceutical companies like Pfizer, Sanofi, GSK and Boehringer Ingelheim.
Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits Ruchika Sharma7 Dec 2022 1:10 PM ISTA Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...
Haleon believes it is not liable for any potential Zantac liabilities Ruchika Sharma20 Sept 2022 3:30 PM ISTHaleon has repeatedly said that it never marketed Zantac in any form in the United States, either as Haleon or as GSK Consumer Healthcare.
GSK notice to Akums, associate on alleged trademark infringement on its Ranitidine brand Zinetac Farhat Nasim8 Sept 2022 6:23 PM ISTNew Delhi: Locking horns over alleged trademark infringement of 'Zinetac', Glaxo Smith Kline (GSK) Pharmaceuticals has issued cease and desist notices...
FDA, EMA found no evidence of causal association between ranitidine and cancer: GSK issues statement Ruchika Sharma13 Aug 2022 12:20 PM ISTNew Delhi: In response to recent speculative commentary regarding U.S. Zantac litigation, GSK plc has issued the following statement regarding Zantac...
Possible carcinogens found in Merck's Sitagliptin drugs Januvia, Janumet: USFDA Ruchika Sharma10 Aug 2022 5:08 PM ISTNew Delhi: The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and...
Sanofi, GSK, Pfizer, Boehringer must face Zantac class-action lawsuits: Court Medical Dialogues Team16 Oct 2021 3:00 PM ISTNew Delhi: Rejecting the arguments by the branded drugmakers in the Zantac lawsuit, in a federal court in Florida, Judge Robin Rosenberg in separate...
New toxic drug impurities detected in some heart pills in US: Bloomberg Ruchika Sharma15 Oct 2021 9:15 AM ISTNew Delhi: Over the past three years, millions of blood pressure pills that contain a probable carcinogen have been recalled around the world. As...
5 firms told to recall Metformin for high levels of probable carcinogen Ruchika Sharma31 May 2020 12:30 PM ISTThe U.S. Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug...
FDA requests withdrawal of all Ranitidine products from market Hina Zahid2 April 2020 5:30 PM ISTThe U.S. Food and Drug Administration has requested that all forms of ranitidine (e.g., Zantac) be removed from the market as new studies indicate...
